
Dupilumab Viable for Atopic Dermatitis During Pregnancy, Breastfeeding
Dupilumab may be considered a viable atopic dermatitis treatment option for pregnant and breastfeeding women, new findings suggest, given both the limited therapy options in this patient population and the drug’s favorable safety profile for such patients. …